sv1za
As filed with the Securities and Exchange Commission on
December 28, 2007
Registration No. 333-145266
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
AMENDMENT NO. 3
TO
Form S-1
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
Peplin, Inc.
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
|
|
|
|
|
Delaware
(State of
Incorporation)
|
|
2834
(Primary Standard
Industrial
Classification Code Number)
|
|
26-0641830
(I.R.S. Employer
Identification No.)
|
6475 Christie Avenue
Emeryville, CA 94608
(510) 653-9700
(Address, including zip code,
and telephone number, including area code, of registrants
principal executive offices)
Michael D.A. Aldridge
Chief Executive Officer
6475 Christie Avenue
Emeryville, CA 94608
(510) 653-9700
(Name, address, including zip
code, and telephone number, including area code, of agent for
service)
Copies to:
|
|
|
Patrick T. Seaver
B. Shayne Kennedy
Latham & Watkins LLP
650 Town Center Drive, 20th Floor
Costa Mesa, CA 92626-1925
(714) 540-1235
|
|
David J. Saul
Gavin T. McCraley
Wilson Sonsini Goodrich & Rosati, P.C.
650 Page Mill Road
Palo Alto, CA 94304-1050
(650) 493-9300
|
Approximate date of commencement of proposed sale to the
public: As soon as practicable after this
Registration Statement becomes effective.
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, check the
following
box. o
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
check the following box and list the Securities Act registration
statement number of the earlier effective registration statement
for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(d) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
The Registrant hereby amends this Registration Statement on
such date or dates as may be necessary to delay its effective
date until the Registrant shall file a further amendment which
specifically states that this Registration Statement shall
thereafter become effective in accordance with Section 8(a)
of the Securities Act of 1933 or until the Registration
Statement shall become effective on such date as the Securities
and Exchange Commission acting pursuant to said
section 8(a), may determine.
EXPLANATORY
NOTE
This Amendment No. 3 to the Registration Statement on
Form S-1
of Peplin, Inc. is filed solely for the purpose of filing
Exhibits 10.22 and 10.23 thereto.
PART II
INFORMATION
NOT REQUIRED IN THE PROSPECTUS
|
|
Item 13.
|
Other
Expenses of Issuance and Distribution
|
Set forth below is a table of the registration fee for the
Securities and Exchange Commission, the filing fee for the
National Association of Securities Dealers, Inc., the listing
fee for the NASDAQ Global Market and estimates of all other
expenses to be incurred in connection with the issuance and
distribution of the securities described in the registration
statement, other than underwriting discounts and commissions:
|
|
|
|
|
Securities and Exchange Commission registration fee
|
|
$
|
2,032
|
|
NASD filing fee
|
|
|
8,000
|
|
NASDAQ Global Market listing fee
|
|
|
*
|
|
Printing and engraving expenses
|
|
|
*
|
|
Legal fees and expenses
|
|
|
*
|
|
Accounting fees and expenses
|
|
|
*
|
|
Transfer agent and registrar fees
|
|
|
*
|
|
Miscellaneous
|
|
|
*
|
|
|
|
|
|
|
Total
|
|
$
|
*
|
|
|
|
|
|
|
|
|
|
* |
|
To be completed by amendments. |
|
|
Item 14.
|
Indemnification
of Directors and Officers
|
Section 145 of the Delaware General Corporation Law
provides that a Delaware corporation may indemnify directors and
officers as well as other employees and individuals against
expenses (including attorneys fees), judgments, fines, and
amounts paid in settlement in connection with specified actions,
suits and proceedings, whether civil, criminal, administrative
or investigative (other than action by or in the right of the
corporation a derivative action), if
they acted in good faith and in a manner they reasonably
believed to be in or not opposed to the best interests of the
corporation and, with respect to any criminal action or
proceeding, had no reasonable cause to believe their conduct was
unlawful. A similar standard is applicable in the case of
derivative actions, except that indemnification only extends to
expenses (including attorneys fees) incurred in connection
with the defense or settlement of such action, and the statute
requires court approval before there can be any indemnification
where the person seeking indemnification has been found liable
to the corporation. The statute provides that it is not
exclusive of other indemnification that may be granted by a
corporations certificate of incorporation, by-laws,
disinterested director vote, stockholder vote, agreement, or
otherwise.
The Delaware General Corporation Law further authorizes a
Delaware corporation to purchase and maintain insurance on
behalf of any person who is or was a director, officer, employee
or agent of the corporation, or is or was serving at the request
of the corporation as a director, officer, employee or agent of
another corporation or enterprise, against any liability
asserted against him and incurred by him in any such capacity,
arising out of his status as such, whether or not the
corporation would otherwise have the power to indemnify him
under Section 145.
Our certificate of incorporation limits the personal liability
of directors for breach of fiduciary duty to the maximum extent
permitted by the Delaware General Corporation Law. Except to the
extent such exemption from liability is not permitted under the
Delaware General Corporation Law, our certificate of
incorporation provides that no director will have personal
liability to us or to our stockholders for monetary damages for
breach of fiduciary duty as a director. However, these
provisions do not eliminate or limit the liability of any of our
directors:
|
|
|
|
|
for any breach of their duty of loyalty to us or our
stockholders;
|
|
|
|
for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law;
|
|
|
|
for voting or assenting to unlawful payments of dividends or
other distributions; or
|
|
|
|
for any transaction from which the director derived an improper
personal benefit.
|
II-1
Any amendment to or repeal of these provisions will not
adversely affect any right or protection of our directors in
respect of any act or failure to act occurring prior to any
amendment or repeal or adoption of an inconsistent provision. If
the Delaware General Corporation Law is amended to provide for
further limitations on the personal liability of directors of
corporations, then the personal liability of our directors will
be further limited to the greatest extent permitted by the
Delaware General Corporation Law.
In addition, our by-laws that will be in effect upon completion
of this offering provide that we must indemnify our directors
and officers and we must advance expenses, including
attorneys fees, to our directors and officers in
connection with legal proceedings, subject to very limited
exceptions.
Acting pursuant to the foregoing, we intend to enter into
indemnification agreements, or Indemnification Agreements, with
each of our directors and officers to indemnify them to the
fullest extent permitted by our certificate of incorporation,
by-laws and Delaware law.
The Indemnification Agreements will:
|
|
|
|
|
confirm to officers and directors the indemnification provided
to them in the by-laws;
|
|
|
|
provide officers and directors with procedural protections in
the event that they are sued in their capacity as director or
officer; and
|
|
|
|
provide additional indemnification rights.
|
We have purchased insurance on behalf of our respective
directors and officers against certain liabilities that may be
asserted against, or incurred by, such persons in their
capacities as our directors or officers, or that may arise out
of their status as our directors or officers, including
liabilities under the federal and state securities laws.
|
|
Item 15.
|
Recent
Sales of Unregistered Securities
|
The following sets forth information regarding all unregistered
securities sold since the registrants formation in
Delaware on July 31, 2007 through the date of this
registration statement:
1. On July 31, 2007, the registrant issued one share
of its Class B common stock to Peplin Limited. Such sale
was deemed to be exempt from registration under the Securities
Act in reliance on Section 4(2) of the Securities Act as a
transaction not involving any public offering. The sale of this
security was made without general solicitation or advertising.
2. Concurrent with the initial filing of this registration
statement, the registrant commenced a process to acquire all the
outstanding shares of its former parent, Peplin Limited,
pursuant to a Scheme of Arrangement. The Scheme of Arrangement
was approved by more than 75% in voting interest and 50% in
number of Peplin Limiteds shareholders present and voting
at a shareholder meeting held on October 1, 2007 and by the
Federal Court of Australia on October 8, 2007. On
October 16, 2007, pursuant to the reorganization, the
registrant issued the shareholders of Peplin Limited one share
of its common stock for every 20 shares of Peplin Limited
that were issued and outstanding. Additionally, the registrant
canceled each of the outstanding options to acquire shares of
Peplin Limited that were listed on the Australian Securities
Exchange and issued replacement options representing the right
to acquire shares of its common stock on the same
1-for-20
basis. The shares and the options issued in the reorganization
were exempt from registration as securities issued pursuant to
Section 3(a)(10) of the Securities Act given that the terms
and conditions of the issuance and exchange were approved, after
a hearing upon the fairness of the terms and conditions, by a
court expressly authorized by law to grant such approval.
3. Upon the consummation of the reorganization, the
registrant granted replacement stock options to purchase
781,073 shares of its common stock to its employees and
consultants (and the employees and consultants of its majority
owned subsidiaries) and its non-employee directors pursuant to
its 2007 Incentive Award Plan, or Plan. These options were
issued in replacement of options to acquire ordinary shares of
Peplin Limited, which were canceled in connection with the
reorganization. Of these options, no options have been exercised
and no shares of the registrants common stock have been
issued and sold to Plan participants. The issuances of
securities described above were exempt
II-2
from registration as securities issued in reliance on
Rule 701 of the Securities Act pursuant to a compensatory
benefit plan approved by the registrants board of
directors.
|
|
Item 16.
|
Exhibits
and Financial Statement Schedule
|
(a) Exhibits
|
|
|
|
|
Exhibit No.
|
|
Description of Exhibit
|
|
|
1
|
.1**
|
|
Form of Underwriting Agreement.
|
|
3
|
.1*
|
|
Certificate of Incorporation of Peplin, Inc.
|
|
3
|
.2*
|
|
Bylaws of Peplin, Inc.
|
|
4
|
.1*
|
|
Form of Common Stock certificate
|
|
4
|
.2*
|
|
Form of Class B Common Stock Certificate
|
|
5
|
.1**
|
|
Opinion of Latham & Watkins LLP
|
|
10
|
.1*
|
|
Implementation Agreement between Peplin Limited and Peplin,
Inc., dated August 8, 2007
|
|
10
|
.2*
|
|
2007 Incentive Award Plan
|
|
10
|
.3**
|
|
Form of Stock Option Agreement
|
|
10
|
.4*
|
|
Form of Indemnity Agreement for Directors and Officers
|
|
10
|
.5*
|
|
Purchase Agreement between Gary Pace and Peplin Limited, dated
June 23, 2006
|
|
10
|
.6*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
Michael Aldridge, dated December 11, 2006
|
|
10
|
.7*
|
|
Employment Agreement between Peplin Limited, Peplin Operations
USA, Inc. and Philip Moody, dated September 8, 2006
|
|
10
|
.8*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
Cheri Jones, dated June 14, 2006
|
|
10
|
.9*
|
|
Employment Agreement between Peplin Limited and David Smith,
dated April 27, 2006
|
|
10
|
.10*
|
|
Letter from Peplin Limited to David Smith, regarding salary
adjustment, dated December 15, 2006
|
|
10
|
.11*
|
|
Employment Agreement between Peplin Limited and Peter Welburn,
dated May 10, 2004
|
|
10
|
.12*
|
|
Letter from Peplin Limited to Peter Welburn regarding role
change and salary adjustment, dated December 15, 2006
|
|
10
|
.13*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
George Mahaffey, dated May 22, 2007
|
|
10
|
.14*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
Arthur Bertolino, dated March 12, 2007
|
|
10
|
.15*
|
|
Lease between Peplin Biotech Ltd and Pine Waters Pty. Ltd.,
dated June 10, 2004
|
|
10
|
.16*
|
|
Lease between Peplin Operations USA, Inc. and Bay Center Office
LLC, dated December 22, 2006
|
|
10
|
.17*
|
|
Lease between Peplin Operations Pty Ltd and Garrels Investments
Pty Ltd, dated May 28, 2007
|
|
10
|
.18*
|
|
Pharmaceuticals Partnerships Program Funding Agreement between
the Commonwealth of Australia and Peplin Operations Pty Ltd,
dated September 22, 2005
|
|
10
|
.19*
|
|
R&D Start Program Grant Agreement between Commonwealth of
Australia acting through the Industry Research and Development
Board and Peplin Operations Pty Ltd, dated September 19, 2003
|
|
10
|
.20*
|
|
Termination and Settlement Agreement between Allergan Sales LLC
and Peplin Limited, dated October 7, 2004
|
|
10
|
.21*
|
|
Form of Subscription Agreement, dated August 8, 2007
|
|
10
|
.22
|
|
Clinical Services Master Agreement between Peplin Operations Pty
Ltd and Omnicare CR, Inc., dated June 1, 2005
|
|
10
|
.23
|
|
Development and clinical supply agreement between Peplin, Inc.
and DPT Laboratories, Ltd., dated October 23, 2007
|
|
10
|
.24*
|
|
Letter from Peplin Limited to David Smith, regarding salary
adjustment, dated October 18, 2007
|
|
21
|
.1*
|
|
Subsidiaries of Peplin, Inc.
|
II-3
|
|
|
|
|
Exhibit No.
|
|
Description of Exhibit
|
|
|
23
|
.1*
|
|
Consent of Ernst & Young (Audit Report of
Peplin Limited)
|
|
23
|
.2*
|
|
Consent of Ernst & Young (Audit Report of
Peplin, Inc.)
|
|
23
|
.3**
|
|
Consent of Latham & Watkins LLP (included in Exhibit 5.1)
|
|
24
|
.1*
|
|
Power of Attorney (included in signature pages)
|
|
|
|
* |
|
Previously filed. |
|
** |
|
To be filed by amendment. |
|
|
|
Management contract or compensatory plan or arrangement. |
|
|
|
Confidential treatment has been requested with respect to
portions of this exhibit. |
(b) Financial Statement Schedules:
Schedules have been omitted because the information required to
be shown in the schedules is not applicable or is included
elsewhere in our financial statements or accompanying notes.
We undertake to provide to the underwriters at the closing
specified in the underwriting agreement, certificates in such
denominations and registered in such names as required by the
underwriters to permit prompt delivery to each purchaser.
Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and
controlling persons of the registrant pursuant to the provisions
summarized in Item 14 above or otherwise, we have been
advised that in the opinion of the Securities and Exchange
Commission, this indemnification is against public policy as
expressed in the Securities Act and is, therefore,
unenforceable. If a claim for indemnification against such
liabilities, other than the payment by us of expenses incurred
or paid by a director, officer or controlling person of ours in
the successful defense of any action, suit or proceeding, is
asserted by a director, officer or controlling person in
connection with the securities being registered in this
offering, we will, unless in the opinion of our counsel the
matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question of whether this
indemnification by us is against public policy as expressed in
the Securities Act and will be governed by the final
adjudication of this issue.
We undertake that:
(1) For purposes of determining any liability under the
Securities Act, the information omitted from the form of
prospectus filed as part of this registration statement in
reliance upon Rule 430A and contained in a form of
prospectus filed by us under Rule 424(b)(1) or (4) or
497(h) under the Securities Act shall be deemed to be part of
this registration statement as of the time it is declared
effective.
(2) For the purpose of determining any liability under the
Securities Act, each post-effective amendment that contains a
form of prospectus shall be deemed to be a new registration
statement relating to the securities offered, and the offering
of these securities at that time shall be deemed to be the
initial bona fide offering.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as
amended, the registrant has duly caused this amendment
no. 3 to the registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the
City of Emeryville, State of California, on December 28,
2007.
PEPLIN, INC.
Philip K. Moody
Chief Financial Officer, Vice President
Finance & Operations
Pursuant to the requirements of the Securities Act of 1933, this
amendment no. 3 to the registration statement has been
signed by or on behalf of the following persons in the
capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Thomas
G. Wiggans
Thomas
G. Wiggans
|
|
Chairman of the Board and
Director
|
|
December 28, 2007
|
|
|
|
|
|
*
Cherrell
Hirst
|
|
Director
|
|
December 28, 2007
|
|
|
|
|
|
*
Michael
Aldridge
|
|
Managing Director and
Chief Executive Officer
(Principal Executive Officer)
|
|
December 28, 2007
|
|
|
|
|
|
/s/ Philip
K. Moody
Philip
K. Moody
|
|
Chief Financial Officer
(Principal Financial and
Accounting Officer)
|
|
December 28, 2007
|
|
|
|
|
|
*
Eugene
Bauer
|
|
Director
|
|
December 28, 2007
|
|
|
|
|
|
*
Gary
Pace
|
|
Director
|
|
December 28, 2007
|
|
|
|
|
|
*
James
Scopa
|
|
Director
|
|
December 28, 2007
|
|
|
|
|
|
*
Michael
Spooner
|
|
Director
|
|
December 28, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Philip
K. Moody
Philip
K. Moody
Attorney-in-Fact
|
|
|
|
December 28, 2007
|
II-5
INDEX TO
EXHIBITS
|
|
|
|
|
Exhibit No.
|
|
Description of Exhibit
|
|
|
1
|
.1**
|
|
Form of Underwriting Agreement.
|
|
3
|
.1*
|
|
Certificate of Incorporation of Peplin, Inc.
|
|
3
|
.2*
|
|
Bylaws of Peplin, Inc.
|
|
4
|
.1*
|
|
Form of Common Stock certificate
|
|
4
|
.2*
|
|
Form of Class B Common Stock Certificate
|
|
5
|
.1**
|
|
Opinion of Latham & Watkins LLP
|
|
10
|
.1*
|
|
Implementation Agreement between Peplin Limited and Peplin,
Inc., dated August 8, 2007
|
|
10
|
.2*
|
|
2007 Incentive Award Plan
|
|
10
|
.3**
|
|
Form of Stock Option Agreement
|
|
10
|
.4*
|
|
Form of Indemnity Agreement for Directors and Officers
|
|
10
|
.5*
|
|
Purchase Agreement between Gary Pace and Peplin Limited, dated
June 23, 2006
|
|
10
|
.6*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
Michael Aldridge, dated December 11, 2006
|
|
10
|
.7*
|
|
Employment Agreement between Peplin Limited, Peplin Operations
USA, Inc. and Philip Moody, dated September 8, 2006
|
|
10
|
.8*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
Cheri Jones, dated June 14, 2006
|
|
10
|
.9*
|
|
Employment Agreement between Peplin Limited and David Smith,
dated April 27, 2006
|
|
10
|
.10*
|
|
Letter from Peplin Limited to David Smith, regarding salary
adjustment, dated December 15, 2006
|
|
10
|
.11*
|
|
Employment Agreement between Peplin Limited and Peter Welburn,
dated May 10, 2004
|
|
10
|
.12*
|
|
Letter from Peplin Limited to Peter Welburn regarding role
change and salary adjustment, dated December 15, 2006
|
|
10
|
.13*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
George Mahaffey, dated May 22, 2007
|
|
10
|
.14*
|
|
Employment Agreement between Peplin Operations USA, Inc. and
Arthur Bertolino, dated March 12, 2007
|
|
10
|
.15*
|
|
Lease between Peplin Biotech Ltd and Pine Waters Pty. Ltd.,
dated June 10, 2004
|
|
10
|
.16*
|
|
Lease between Peplin Operations USA, Inc. and Bay Center Office
LLC, dated December 22, 2006
|
|
10
|
.17*
|
|
Lease between Peplin Operations Pty Ltd and Garrels Investments
Pty Ltd, dated May 28, 2007
|
|
10
|
.18*
|
|
Pharmaceuticals Partnerships Program Funding Agreement between
the Commonwealth of Australia and Peplin Operations Pty Ltd,
dated September 22, 2005
|
|
10
|
.19*
|
|
R&D Start Program Grant Agreement between Commonwealth of
Australia acting through the Industry Research and Development
Board and Peplin Operations Pty Ltd, dated September 19, 2003
|
|
10
|
.20*
|
|
Termination and Settlement Agreement between Allergan Sales LLC
and Peplin Limited, dated October 7, 2004
|
|
10
|
.21*
|
|
Form of Subscription Agreement, dated August 8, 2007
|
|
10
|
.22
|
|
Clinical Services Master Agreement between Peplin Operations Pty
Ltd and Omnicare CR, Inc., dated June 1, 2005
|
|
10
|
.23
|
|
Development and clinical supply agreement between Peplin, Inc.
and DPT Laboratories, Ltd., dated October 23, 2007
|
|
10
|
.24*
|
|
Letter from Peplin Limited to David Smith, regarding salary
adjustment, dated October 18, 2007
|
|
21
|
.1*
|
|
Subsidiaries of Peplin, Inc.
|
|
23
|
.1*
|
|
Consent of Ernst & Young (Audit Report of
Peplin Limited)
|
|
23
|
.2*
|
|
Consent of Ernst & Young (Audit Report of
Peplin, Inc.)
|
|
23
|
.3**
|
|
Consent of Latham & Watkins LLP (included in Exhibit 5.1)
|
|
24
|
.1*
|
|
Power of Attorney (included in signature pages)
|
|
|
|
* |
|
Previously filed. |
** |
|
To be filed by amendment. |
|
|
Management contract or compensatory plan or arrangement. |
|
|
Confidential treatment has been requested with respect to
portions of this exhibit. |
II-6